Jeremy Sayer
Overview
Explore the profile of Jeremy Sayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rader F, Kirtane A, Wang Y, Daemen J, Lurz P, Sayer J, et al.
EuroIntervention
. 2022 Aug;
18(8):e677-e685.
PMID: 35913759
Background: While the blood pressure (BP)-lowering effect of renal denervation (RDN) has been established, long-term durability is a key prerequisite for a broader clinical implementation. Aims: Our aims were to...
2.
Watson N, Karamasis G, Stathogiannis K, Potter M, Damian M, Cook C, et al.
Resuscitation
. 2021 Dec;
171:114-120.
PMID: 34848275
Aim: To determine the safety and feasibility of an early (12 h) waking and extubation protocol for out-of-hospital cardiac arrest (OHCA) patients receiving targeted temperature management (TTM). Methods: This was...
3.
Sanghvi K, Wang Y, Daemen J, Mathur A, Jain A, Dohad S, et al.
Cardiovasc Revasc Med
. 2021 Oct;
39:58-65.
PMID: 34620570
Purpose: To assess the variability of renal artery (RA) anatomy and presence of RA-pathology in patients with mild-to-moderate hypertension enrolled in the RADIANCE-HTN SOLO trial. Background: RADIANCE-HTN SOLO was a...
4.
Azizi M, Daemen J, Lobo M, Mahfoud F, Sharp A, Schmieder R, et al.
JACC Cardiovasc Interv
. 2020 Dec;
13(24):2922-2933.
PMID: 33357531
Objectives: This study reports the 12-month results of the RADIANCE-HTN (A Study of the ReCor Medical Paradise System in Clinical Hypertension) SOLO trial following unblinding of patients at 6 months....
5.
Azizi M, Schmieder R, Mahfoud F, Weber M, Daemen J, Lobo M, et al.
Circulation
. 2019 Mar;
139(22):2542-2553.
PMID: 30880441
Background: The multicenter, international, randomized, blinded, sham-controlled RADIANCE-HTN SOLO trial (A Study of the ReCor Medical Paradise System in Clinical Hypertension) demonstrated a 6.3 mm Hg greater reduction in daytime...
6.
Azizi M, Schmieder R, Mahfoud F, Weber M, Daemen J, Davies J, et al.
Lancet
. 2018 May;
391(10137):2335-2345.
PMID: 29803590
Background: Early studies suggest that radiofrequency-based renal denervation reduces blood pressure in patients with moderate hypertension. We investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood...
7.
Watson N, Potter M, Karamasis G, Damian M, Pottinger R, Clesham G, et al.
Ther Hypothermia Temp Manag
. 2018 Mar;
8(3):150-155.
PMID: 29578831
Mild therapeutic hypothermia (MTH 33°C) post out-of-hospital cardiac arrest (OHCA) is widely accepted as standard of care. However, uncertainty remains around the dose and therapy duration. OHCA patients are usually...
8.
Islam S, Hampton-Till J, Watson N, Mannakkara N, Hamarneh A, Webber T, et al.
Resuscitation
. 2015 Sep;
97:61-7.
PMID: 26410565
Introduction: Trials demonstrate significant clinical benefit in patients receiving therapeutic hypothermia (TH) after cardiac arrest. However, incidence of mortality and morbidity remains high in this patient group. Rapid targeted brain...
9.
Cheong J, Showkathali R, Partridge W, Chauhan A, Sayer J
J Cardiovasc Med (Hagerstown)
. 2012 Jan;
12(12):908-11.
PMID: 22263237
No abstract available.
10.
Cheong J, Showkathali R, Partridge W, Chauhan A, Sayer J
J Cardiovasc Med (Hagerstown)
. 2010 Oct;
12(10):768-71.
PMID: 20935570
No abstract available.